Journal Name: Journal of Clinical Oncology
Journal Type: Q1
ISSN: 0732183X, 15277755
Country: United States
Subject Area and Category: Biochemistry, Genetics and Molecular Biology Cancer Research Medicine Medicine (miscellaneous) Oncology
Publisher: Lippincott Williams and Wilkins
Research Ranking: 3
Publication Type: Journals
H-Index: 624
Coverage: 1983-2023
Editors-in-Chief: Jonathan W. Friedberg
Research Impact Score: 79.3
Impact Factor: 42.1
SCIMAGO SJR: 10.639
APC Cost: $3,800
Homepage: https://ascopubs.org/journal/jco
Submission Link: https://ascopubs.org/journal/jco/
Contact Email: jco@asco.org
Address: 2318 Mill Rd #800, Alexandria, VA 22314, USA
Overview
The Journal of Clinical Oncology (JCO) is one of the most influential and widely recognized peer-reviewed medical journals dedicated to clinical cancer research. Published by the American Society of Clinical Oncology (ASCO), JCO provides cutting-edge insights into cancer treatment, patient care, and emerging therapeutic advancements. This journal is a trusted resource for oncologists, researchers, and healthcare professionals seeking the latest evidence-based findings in oncology.
Scope and Mission
The Journal of Clinical Oncology aims to improve cancer care through high-quality clinical research and innovation. The journal covers a broad range of oncology-related topics, including:
- Clinical Trials & Research: Publishing groundbreaking studies on novel cancer treatments, drug development, and patient outcomes.
- Precision Medicine: Insights into the latest advancements in personalized cancer therapy and genomics.
- Immunotherapy & Targeted Therapies: Research on monoclonal antibodies, checkpoint inhibitors, and CAR-T cell therapy.
- Survivorship & Palliative Care: Addressing long-term patient outcomes, quality of life, and supportive care interventions.
- Guidelines & Best Practices: Expert recommendations for cancer treatment protocols and patient management.
Key Features and Impact
High-Quality Peer-Reviewed Research
JCO maintains a rigorous peer-review process to ensure the integrity and reliability of published studies. Its editorial board comprises leading oncologists and researchers who evaluate submissions based on scientific merit, clinical relevance, and innovation.
Impact Factor and Global Recognition
JCO boasts a high impact factor, making it a premier journal in the field of oncology. The journal’s influence extends globally, with contributions from renowned cancer research institutions, universities, and hospitals worldwide.
Open Access and Special Editions
While JCO operates primarily as a subscription-based journal, it offers open-access articles for significant breakthroughs in oncology. Special editions focus on specific cancer types, treatment advances, and emerging trends in oncology research.
Why JCO Matters for the Oncology Community
The Journal of Clinical Oncology serves as a crucial platform for disseminating vital research that shapes cancer treatment paradigms. Oncologists rely on JCO to stay updated on groundbreaking studies, evolving treatment protocols, and clinical best practices. The journal also fosters collaboration among oncology professionals by publishing multi-institutional studies and consensus guidelines.
About
The Journal of Clinical Oncology (JCO) is one of the most prestigious peer-reviewed medical journals dedicated to cancer research and treatment. Published by the American Society of Clinical Oncology (ASCO), JCO serves as a vital resource for oncologists, researchers, and healthcare professionals worldwide. The journal covers cutting-edge clinical research, innovative treatment approaches, and significant advancements in oncology.
About the Journal of Clinical Oncology
Since its establishment in 1983, the Journal of Clinical Oncology has been at the forefront of oncology research, providing high-impact articles that shape clinical practice. With a strong reputation for scientific integrity and rigorous peer review, JCO publishes original research, reviews, editorials, and clinical guidelines that contribute to improving cancer diagnosis, treatment, and patient care.
Key Features of JCO
1. High-Impact Research
JCO publishes groundbreaking studies that influence oncology care, including clinical trials, targeted therapies, immunotherapies, and precision medicine. The journal’s research articles provide valuable insights for oncologists and researchers striving to enhance cancer treatment.
2. Diverse Oncology Topics
The journal covers a wide range of topics, including:
- Breast cancer, lung cancer, prostate cancer, and other malignancies
- Hematologic oncology
- Immunotherapy and targeted treatments
- Radiation oncology and surgical oncology
- Supportive care and palliative medicine
- Epidemiology and cancer prevention
3. Clinical Guidelines and Expert Opinions
JCO publishes expert-reviewed guidelines and recommendations that help oncologists make informed decisions regarding patient care and treatment strategies.
4. Specialized Sections
The journal features dedicated sections such as JCO Global Oncology, JCO Clinical Cancer Informatics, and JCO Precision Oncology, which focus on different aspects of cancer research and treatment.
5. Accessibility and Open Access
While JCO is primarily a subscription-based journal, selected articles are available as open-access content. This ensures that crucial oncology research is accessible to a broader audience, including healthcare providers and researchers in developing countries.
Why JCO Matters for the Oncology Community
Advancing Cancer Treatment
JCO plays a crucial role in advancing cancer treatment by disseminating the latest clinical research findings. Its articles influence the development of new drugs, innovative therapies, and personalized treatment approaches.
Evidence-Based Decision-Making
Oncologists and healthcare providers rely on JCO’s research and clinical guidelines to make informed treatment decisions, ultimately improving patient outcomes.
Global Impact
With contributions from leading oncologists and researchers worldwide, JCO fosters collaboration and knowledge-sharing in the fight against cancer.
Scope
The Journal of Clinical Oncology (JCO) is a leading peer-reviewed medical journal dedicated to advancing the field of clinical oncology. Published by the American Society of Clinical Oncology (ASCO), the journal serves as a vital resource for oncologists, researchers, and healthcare professionals worldwide. It provides cutting-edge research, evidence-based practices, and innovative treatment strategies aimed at improving cancer care and patient outcomes.
Key Areas of Focus
The Journal of Clinical Oncology covers a broad range of topics within the field of oncology, including but not limited to:
- Clinical Research and Trials – JCO publishes high-quality clinical trials that shape the future of cancer treatment. These studies provide insights into new therapies, drug efficacy, and patient response rates.
- Cancer Prevention and Early Detection – The journal emphasizes strategies for cancer prevention, risk assessment, and early detection methods that can improve survival rates.
- Personalized and Precision Medicine – JCO explores the role of genomics, biomarkers, and targeted therapies in developing individualized treatment plans.
- Immunotherapy and Targeted Therapies – With the growing significance of immunotherapy in cancer treatment, JCO highlights research on immune checkpoint inhibitors, monoclonal antibodies, and emerging targeted drug therapies.
- Palliative and Supportive Care – JCO addresses ways to enhance the quality of life for cancer patients, including pain management, psychological support, and survivorship care.
- Oncology Guidelines and Best Practices – The journal provides updated clinical practice guidelines that help oncologists make informed decisions regarding patient care.
- Health Disparities and Global Oncology – JCO is committed to addressing healthcare disparities and promoting equitable cancer care worldwide through research and policy discussions.
Types of Publications
JCO features various types of content, including:
- Original Research Articles – Peer-reviewed studies on new oncology treatments and methodologies.
- Review Articles – Comprehensive overviews of specific cancer-related topics.
- Editorials and Commentaries – Expert opinions and discussions on recent advancements in oncology.
- Clinical Practice Guidelines – Evidence-based recommendations for oncologists.
- Case Reports and Letters – Unique clinical cases and professional correspondence discussing emerging trends in oncology.
Impact and Readership
The Journal of Clinical Oncology has a high impact factor, making it a trusted source of information for the global oncology community. It reaches a diverse audience of oncologists, researchers, healthcare policymakers, and medical professionals interested in the latest advancements in cancer care.
With its rigorous peer-review process and commitment to scientific excellence, JCO continues to drive innovation in oncology, improving patient outcomes and shaping the future of cancer treatment.